Altair
Skip to content

Trading Analysis Report: CRM

Analysis date: 2026-10-14 · Model: claude-opus-5-5 · AI-generated, not financial advice.

  • Analysis date: 2026-10-14
  • Rating: Hold
  • Generated: 2026-10-14 17:41:57
  • TradingAgents 0.6.0: anthropic, deep claude-opus-5-5, quick claude-sonnet-5-5
  • Analysts: market, sentiment, news, fundamentals; research debate rounds 5, risk debate rounds 5
  • Data vendors: core_stock_apis yfinance, technical_indicators yfinance, fundamental_data sec_edgar,yfinance, news_data yfinance, macro_data fred, prediction_markets polymarket

V. Portfolio Manager Decision

Rating: Hold

Executive Summary: Hold CRM: keep existing exposure at standard weight and do not buy at market near 235.95. That price sits mid-range, between the 220-223 lows and the 238-240 / 249.45 ceiling, and the analysts agreed it offers no payoff edge. Trim any excess above standard into 238-249. On a daily close below 220.29, take the excess to standard and then remove a further quarter of standard; on a close below 214, cut to half of standard. Books below standard may add toward standard, never above it, only after a pre-written graded Q2 10-Q gate passes within about three trading days. The adds are a 25% buy on a reclaim of 222 (stop under the retest low, no higher than 214), a rebuild on a reclaim of 205 (stop about 196), or a 10% breakout sleeve after two closes above 249.45. Gross adds are capped at 50% of standard before the Q3 FY27 print, no buy fills within two sessions of it, and that print's margins set the next rating move.

Price target: $243. - Valuation (primary): $10B midpoint FCF after SBC and interest, divided by a 5% fair FCF yield, gives about $200B. Divided by about 823M shares, that is about $243. - Earnings cross-check: about $10.2 of run-rate GAAP EPS times 24x (the midpoint of 23-25x) gives about $245. - Technical check: $243 sits inside the 238-249.45 range, near the 243.41 upper Bollinger band and below the daily SuperTrend flip. - The implied move is about +3% from 235.95, consistent with Hold.

Current Price: 235.95

Price Target: 243.0

Confidence: Medium

Time Horizon: 2-3 months

IV. Risk Management Team Decision

Aggressive Analyst

Aggressive Analyst: Neither of you has spoken yet, so I'll open with the case and answer the objections I expect.

I'm backing Hold, and I think it's the aggressive call, because the edge in this plan is the price you pay, not the label on the action. Buying at market, 235.95 with a stop at 214, risks about 22 points to make 28 if the stock revisits the 263.97 high. That's roughly 1.3 to 1, and only 0.6 to 1 if the target is the 249.45 daily flip level. That's a bad trade. At 222 with a stop at 214, you risk 8 points to reach 264, which is about 5 to 1, and 3.4 to 1 even if you only reach 249. Being aggressive means paying for that asymmetry, and chasing doesn't.

The setup also gives the bulls a lot. Weekly SuperTrend is up with its stop at 197.98, nearly 19% below the price. The stock sits above its 10 EMA, 50 SMA and 200 SMA, and the 50 SMA is still rising. It took a 22.6% gap on 55 million shares, gave back 58% of that gap-day gain at the low, and still holds about two-thirds of it. RSI bottomed at 43.94 and never came near oversold. Four separate sessions printed lows between 220 and 223. I can't claim that's verified support, since the technical report didn't test it, but buyers keep showing up there. That's what an orderly pullback looks like, not distribution.

On fundamentals, the market is paying 14.7x forward earnings, with a PEG of 0.85, for a business with about 35% FCF margins and roughly $15 billion of free cash flow. That's about a 7.8% FCF yield on the conservative filing-derived number. Diluted shares are down about 15% year over year, and an independent director put $1 million in at $239 three and a half weeks ago. That's a business insiders are willing to buy into.

Now the objections. The conservative case will lead with gross margin falling four quarters running, from 78.1% to 76.6%, with operating income flat on 10.8% growth. That's real, and it's why I wouldn't say Overweight. But the margin trend is the reason to wait for 222 rather than a reason to leave. Operating margin is still 20.5%, three years ago it was 14%, and free cash flow is growing double digits. A franchise like that doesn't need perfection to earn a decent return from 222.

They'll also say Q2 EPS of $4.29 was inflated by about $1.4 billion of non-operating items, and the leverage jump is alarming. Liabilities to equity went from 0.59x to 1.86x, with about $42 billion of implied debt. They're right on both, and I won't pretend otherwise. Forward EPS of $16.02 is probably non-GAAP, and on normalized trailing numbers the stock is nearer 26x. But that's what the 10-Q gate in the plan is for. Reading the net income composition, the debt terms and the interest expense is a reading assignment, not a waiting period. It costs almost nothing and covers the biggest unknown.

They'll lean on macro: 97% odds of no cuts, 86% odds of another hike, hot CPI, Oracle tumbling. It's a headwind. But recession odds are 8%, so the risk is multiple compression, not an earnings collapse, and CRM is already at 14.7x forward. On the day Oracle got hit, CRM closed down under 1%, though that last bar may be a partial session. And the plan doesn't ask anyone to bet against the Fed. It sizes for a gap to 205 with everything filled costing at most about 5% of target value.

The neutral camp will say that if you're this uncertain, just hold what you have and add nothing. I'd push back. A pure "stay put" ignores that the plan has defined triggers on both sides: a retest of 222 that closes back above it, or a daily close over 249.45 on rising volume. That's how you get to own more of a stock with a 29% gap to its monthly SuperTrend at 285.97, without buying the middle of the range.

I'll also concede where my side is weak. Sentiment is a thin signal, since one account wrote 9 of the 30 StockTwits posts and 7 of the 11 bullish tags. OBV is weak and the bounce has come on light volume. The monthly SuperTrend is still down, and I can't tell you what drove the August gap because my tools don't say. That's exactly why I'm not pounding the table to buy 236.

The bottom line is that going Underweight sells a sound, cash-generating franchise after a re-rating, with insiders on the other side of the trade. Overweight now overpays for a name still below the daily SuperTrend. Hold with live triggers, a 214 stop and a hard cap on gap risk lets us take the upside if it comes and keeps the damage small if it doesn't. My vote is Hold. Aggressive Analyst: Let me start with what I'll take, because most of it makes the trade better, not smaller.

Neutral is right that 5-to-1 was a headline number, and Conservative is right that an 8-point stop on a stock with an 8.44 ATR sits inside one day's range. If the real order is buying the reclaim near 225 with the stop at 214, it's about 3.5-to-1 to 264 and 2.2-to-1 to 249. Even Conservative's wider-stop math, 1.6 to 2.5-to-1, only needs a hit rate of roughly 29 to 38 percent to break even. Buying 235.95 at market, at 0.6 to 1.3-to-1, needs 44 to 62 percent. So the ratio argument survives the critique, and what changes is the order. I'll take a buy on the reclaim instead of the touch, a stop just under the actual retest low capped at 214, and size from dollars at risk. That's a better entry, and a better entry is the aggressive move.

I'll also drop two claims. "Orderly pullback" was too strong with OBV going from -1.6 million to -100 million. The bounce is real but unproven, which is why A waits for a reclaim. And nothing in my case depends on insiders. Kirk's last buy is 1.4% underwater, Morfit is about 9% underwater, and the big sales are exercise-and-sell.

On the 10-Q, Conservative says to read it before deciding, not in parallel. Fine, it's free, so do it today and arm the orders sooner. Neutral's definition of a pass is the right one: the $1.4 billion item identified, debt terms and interest checked, organic growth and cRPO read, and the August catalyst named. If you're overweight, read it first. If it isn't done by the time we're at 238, trim to standard anyway, which the plan already does.

Now where I'm not moving.

The 50 SMA trim fails Conservative's own test. He called my stop too tight because it sits inside one ATR. But 235.95 minus 227.73 is 8.22, inside the same 8.44 ATR, so it fires on an ordinary day. It's also a line rising about a point a day with pre-gap closes near 200 still rolling off. Neutral is right to drop it. I'll accept Neutral's first slice on a close below the 220 cluster. My evidence for buyers was those four lows, so if a close takes out the lowest one at 220.29, I shouldn't keep the thesis after its evidence is gone. Cut to half at 214 after that.

The extra confirmations on C add lag and no information. A MACD signal cross and OBV turning up are computed from the same price move they're meant to confirm, and a run from 236 to 250 will produce both. Neutral's filter of a second close or no give-back at least tests whether the level holds. Waiting also isn't free. Conservative's version means paying at least 13.5 points, about 5.7%, above today's price. Neutral is right that C is a momentum bet, about 1-to-1 to 264 and 2.7-to-1 to 286, so I accept it small, with the monthly SuperTrend as the target.

The real disagreement left is the 25% cap and the one-live-tranche rule. For A and B, sequential is right, since in a decline A's stop sits above B's entry. But A and C aren't alternatives. They're a pyramid. The only way both are live is that the stock is working. When C fires, move A's stop up to C's stop near 236. With equal sizes, A locks in about 11 points and C loses about 13.5 if stopped, so the pair risks roughly 2.5 points net, less than the 11 points A risked alone. Adding C then raises exposure while lowering open risk. A 25% cap forbids exactly the scenario where we're right. Gap risk is already bounded by the plan's rule that a gap to 205 with everything filled costs no more than about 5% of target value. That constraint binds, not the tranche count. So keep 50% cumulative, one live tranche in a decline, and allow a small C on top of A in a rally with A's stop trailed.

On valuation and rates, Conservative's 6.7% enterprise-value yield and Neutral's after-interest yield land on the same number, so call it 7%, decent but not cheap. Neutral's debt arithmetic matters most here. Charging all $42 billion at 5% is about $2.1 billion, a seventh of FCF. Adding 75 basis points on every dollar being floating is roughly $315 million, about 2% of FCF. That's an earnings sensitivity, not a solvency problem. I'll also concede Conservative's FCF point: Q1 grew 4%, and Q2's jump from a small base did most of the lifting in the 10.9% H1 number. The real test is the cRPO and guidance in the 10-Q.

Multiple compression is a legitimate risk. But nobody here has the CPI print, the 10-year or the VIX, because the macro pull failed. The hike markets are under $1 million each, so we're arguing a regime from headlines and thin prediction markets. That's an argument for leaning on structure rather than forecasts. A 10% market drop takes CRM to about 206, which is the plan's B scenario. B is a reclaim buy at 205 with a stop at 196, just under the weekly SuperTrend stop at 197.98 and the 200 SMA at 198.50. The plan already treats that drop as an entry.

On the August gap, we can't name the catalyst, but that cuts both ways. If it was the Q2 report, a 22.6% move on 55 million shares was set mostly by people who had the release in hand, including the net income composition. I can't prove that was more than a headline-quality re-rating, and I'm not building on it. I also wouldn't build the opposite on it. The 10-Q gate is how we find out.

Conservative says if he's wrong the cost is a later entry, and if I'm wrong it's a gap through a tight stop. The gap loss is the sized number, capped at about 5% of target value. The later entry costs 5.7% on every share and arrives behind redundant signals.

My vote stays Hold, amended. Holders stay put, trim to standard into 238 to 249 if overweight, take a first slice below 220 and cut to half at 214. New money comes only after the 10-Q passes. A is a reclaim buy sized from dollars at risk, B is a reclaim of 205, and C is small on a held breakout targeting 286. A may be pyramided with its stop trailed, under a 50% cumulative cap. This version pays us more when we're right, not just hurts us less when we're wrong. Aggressive Analyst: I'll start with what I'm taking, because it's most of the round. Neutral's sleeve math checks out. C at 10% of target costs about 1.8% in a gap to 205 and about 2.1% in a gap to 198. A at a quarter of target costs 2.2% and 3.0%. The pair comes to roughly 4.0% and 5.1%, so one number clears both stress points. Conservative gets his 198 and I keep a C worth having.

I'll also take the counting rule. Stopped tranches count against the 50% gross cap, because two failed reclaims is information. Eighteen million shares on the breakout day is a real number, and a second close above 249.45 is a real price filter, so C needs both. The gate gets three outcomes, with thresholds written before anyone opens the filing and a few trading days to finish.

Neutral put placeholders on the fail side, so let me put them on the pass side too. A pass is at least about three-quarters of the $1.4 billion tied to identifiable one-time items, annualized interest under roughly 15% of operating income, cRPO growth within a couple of points of reported revenue growth, and the August catalyst named. A fail is what Neutral said: the item can't be tied to something one-time, interest near a fifth of operating income or worse, or clearly deteriorating cRPO. Everything between holds the core and keeps adds off. If the deadline passes with no read, that's the middle outcome. Anyone above standard weight then trims to standard at the next close at or above 238. That's under 1% from here, so Conservative and I barely disagree on that point.

One caution on the interest question, for everyone including me. Q2's normalized net-income ratio is not evidence, because the $1.4 billion was backed out by assuming Q1's ratio. The answer was baked into the question. Only the filing settles it.

Now the places I still disagree.

Conservative says missing CPI, 10-year and VIX data is a reason to size down. The FRED failure was a missing API key, not information from the market. Neutral is right that the response is rules that don't need the forecast, and dollars-at-risk sizing plus a gap budget are those rules. If unknown macro justified shrinking exposure, it would hit the standard-weight core before a 10% sleeve, and nobody is proposing that. The print works the same way. Gap risk comes with owning the stock at all. The mirror image of gap day from 250 lands near 193 and costs the full A-plus-C sleeve about 5.8% of target. That's the entire worst case for the part we're arguing about, a little over the budget we agreed on, not a blowup.

On the 238 to 240 stall, I read a range with edges, not distribution. There are four lows between 220.29 and 222.89, and three touches of 238 to 240, though today's bar may be a partial session. In a box about 8% wide, you don't predict the exit. You size small, you're positioned for either edge, and you put a stop just beyond it. That's A and C. It's also why 236 is the worst place to buy, since it's mid-box and pays nothing.

I do have a warning about piling on filters. Every one moves C's entry up. At 250 with a stop at 236, C risks 14 points for 36 to the monthly SuperTrend, about 2.6 to 1, and needs a hit rate near 28%. At 253 after a second close, it risks 17 for 33, about 1.9 to 1, and needs about 34%. I'll take that at 10% of target. But two filters is the limit, because past that C stops being asymmetric and becomes a chase with extra steps.

On valuation, I accept 23 to 25x on a roughly $10 run-rate, and I accept that the $5 billion of add-backs between that and $16.02 is the real question. But stock comp has a size. Every billion takes about half a point off the 7.8% yield on market cap. Even $4 billion leaves free cash flow after stock comp near 5.8%. I've never said that's cheap. It's a decent business, and the entry I'm asking for is about 5% below today's price. A at a 225 reclaim risks 11 points for 39 to the 264 high, about 3.5 to 1, and needs a hit rate near 22%. Those are the odds that pay for the unknowns in the filing.

Conservative's last line was that if I'm wrong, we own the most stock at the highest prices going into a print. That overstates it. Live exposure in a decline is one tranche. In a rally it's A with a trailed stop plus a 10% C that exists only after two closes above 249.45 on real volume. The highest-priced piece is a tenth of target. I'll give him one cheap rule, though: once the Q3 date is confirmed, nothing new gets armed in the last couple of sessions before it. A breakout bought the day before earnings isn't a breakout trade, it's a coin flip with a gap attached.

So my vote is Hold, amended, and I think the amended version is the aggressive one. Holders stay at standard weight. They trim to standard into 238 to 249 if overweight, take a quarter off on a close below 220.29, and cut to half at 214. New money waits for a gate pass. A is a 25% reclaim buy with its stop under the actual retest low and no higher than 214. B is a reclaim of 205 with a stop near 196. C is 10% on two closes above 249.45, the first on 18 million shares, targeting 286, with A's stop trailed up. One tranche is live in a decline, stopped tranches count against the 50%, and nothing gets armed right before the print.

What's left between us is measured in tenths of a percent of target. If Conservative is right, we skip a failed breakout and eat a bounded 4% to 6% of target on a sleeve. If I'm right, A and C are how we get paid for a stock still 21% below its monthly flip at 285.97, without paying 236 for the privilege. Aggressive Analyst: We're down to wording in the plan, so I'll take the points in order and say where I still push.

Neutral's catch on "target" is right, and I read it as standard weight too. The ladder fills an underweight position up to standard and no further, so each tranche is the smaller of its size and the room left below standard. That answers Conservative's worry about owning the most stock at the highest prices, because nobody ends up above standard. It also means that for someone already at standard, the add side is dormant and the plan is just hold plus trim and cut rules. The upside half of this plan is for underweight books and new money. I'm fine saying so out loud.

On A, I accept everything. A close under 220.29 cancels an unfilled A and halves a filled one, and re-arming needs a fresh reclaim of 222. Neutral is right that Conservative's own ATR objection would apply to a 4.7-point cut. But a close-based rule is much quieter than a stop order, so I'll take it.

On B, I'll take Neutral's version. It's a rebuild toward standard, it needs a reclaim of 205 and not a touch, the cause check applies, it stays off if the gate failed, and it counts against the 50%. I won't give up that B can exist, though. Conservative calls selling at 214 and buying at 205 incoherent. I'd say the 214 cut is a risk limit that says to stop trusting the consolidation. A close back above 205 is new evidence that the gap origin held, with the 200 SMA and weekly SuperTrend stop just below. If the only way back in after a cut is on a recovery, every stop-out gets rebuilt above where we sold, and that makes whipsaw a built-in cost.

Conservative is also right that a payoff ratio isn't an edge. The 22% for A is what a driftless walk requires, and nobody has shown that the reclaim lifts the odds above it. What I have is circumstantial. The stock traded into the 220-223 area four times between 9/28 and 10/8 and never closed below 224.56, the weekly trend is up and the 50 SMA is rising. That's a reason to try the hypothesis, not proof of it. So the honest case for A is its cost. If it fails at 214, it costs about 1.2% of standard weight, and a bit less with the 220.29 halving rule. A hypothesis that cheap is worth testing, and Neutral's point stands that the core at 236 isn't a ratio argument either.

On valuation we've landed in the same place: five and a bit percent after stock comp and interest, fair and not a margin of safety. Entering at 225 instead of 236 only adds a quarter point of yield. But a 4.7% lower price is the one thing we control, and it's what pays for being wrong about the business.

On the gate, I have two things to fix and one to resist. First, my own number. I said a pass was interest under 15% of operating income. That's $1.4 billion annualized, about 3.3% on $42 billion, which is below any plausible cost. As written, it would almost never arm anything. Operating income is also after acquired amortization, so EBITDA is the cleaner base. I'd restate it this way: - Pass: annualized interest of about $1.9 billion or less, which is 15% of EBITDA and about a fifth of operating income. - Fail: $2.8 billion or more, which is Neutral's 30% of operating income. That requires about 6.7% on the entire $42 billion, so it triggers only if the debt is dearer than anything we've assumed. - Middle: everything in between.

Measure it on the latest quarter's run rate, not trailing, since the debt was raised during the year.

Second, I take Neutral's dollar FCF leg, about $10 billion after stock comp and interest, and I agree a yield threshold is backwards because it fails mechanically as price rises. I also take Conservative's organic cRPO leg and the question of whether the $16.02 carries the new interest.

What I resist is requiring all six legs to pass. Make the $1.4 billion item, interest and FCF in dollars the hard legs. Make organic cRPO, the August catalyst named and the $16.02 basis soft legs, and require two of three. Write it all down before opening the filing so nothing bends toward the price. A gate nobody can pass is just a polite way of saying don't buy, and that isn't Hold. Most of these legs are answerable in one sitting with the Q2 release, the 10-Q and the call, so a three-trading-day deadline is realistic.

On quiet windows, I side with Neutral. Once the Q3 date is confirmed, nothing gets armed the session before it. The pause before the Fed or CPI applies to C only, since C is the one buying near the highs. Peer prints don't get a window. Earnings season would leave the ladder off most weeks, and the gap budget already covers ordinary event risk for A and B.

My vote is Hold, amended. Holders stay at standard weight, trim to standard into 238 to 249 if above it, take a quarter off on a close under 220.29, and cut to half at 214. Underweight books fill toward standard, never past it, and only after a gate pass. A is a 25% reclaim buy with its stop under the retest low and no higher than 214. B is a 205 reclaim rebuild after the cause check. C is 10% after two closes above 249.45, the first on 18 million shares, targeting 286, with A's stop trailed up. One tranche is live in a decline, stopped tranches count against the 50% cap, and nothing is armed right before the Q3 print.

If Conservative is right, we skip a failed breakout and eat about 1% of standard weight on A. If I'm right, an underweight book owns a fair-priced compounder about 5% below today's price and gets a small piece of the breakout. That is the version of Hold I'd put my name on. Aggressive Analyst: Conservative found real holes this round, and Neutral's repairs mostly close them. I'll take those quickly and spend my time on two places where the fixes still leak.

Writing the pre-print rule in terms of fills is better than what I had. Every trigger is close-based, so the order lands at the next open. The 8/27 bar opened at 229.65 off a 205.26 close, which fits a release after the close on 8/26, but that's inference. So the first job is the IR calendar. Until the date is confirmed, nothing buys past mid-November. After that, no buy order fills within two sessions of the report or at the open after it, and cuts stay live.

The overweight fix is right too. A holder at 150 who never saw 238 goes to standard first and then takes the quarter off on the same close, ending at 75. The excess was never something this plan supported. B's mechanical cause check beats my judgment call, because a one-session drop of about 7% that lags the named peers by four points or more shuts B off automatically. B can't buy the aftermath of its own earnings miss. I'll accept that C's first close can't land on a named-peer print day, since that close carries the 18 million share test and a ServiceNow or Microsoft print can produce that volume without any CRM demand behind it. And on framing, my one percent was the orderly case. The numbers to carry are the gap numbers: 2.2 to 3 percent on A, 4 to 6 on the A and C sleeve, and about 6 if gap day repeats from 250.

Now the gate, where I'd fix two things before anyone opens a filing.

First, the interest leg and the FCF leg charge the same dollars. Neutral's FCF bar is $10 billion after stock comp and interest, so a bad interest finding fails the interest leg and pushes FCF toward its fail line. One finding becomes two failing legs, and two failing legs halve the core. We said that should take two independent findings. The fix is to measure the FCF leg after stock comp only and score interest on its own. Moving a mid-range $1.5 billion interest charge out of Neutral's bar gives roughly $11.5 billion to pass and $9.5 billion to fail. Our own estimate is $15.2 billion less $3 to 4 billion of stock comp, or $11.2 to 12.2 billion. The pass line sits in the middle of that range, so it's a real test and not a gimme.

Second, the $16.02 isn't a filing number. It's a feed consensus, so the 10-Q can't say what it includes. What the release can show is the company's own bridge from GAAP to non-GAAP guidance, which tells us whether stock comp and acquired amortization sit outside it and whether new interest sits inside it. Define "answered" as that bridge being read. Otherwise a disclosure nobody can answer parks every outcome in the middle by default, and that's the polite no I warned about last round.

I also still push on the filters. C now needs a gate pass, two closes over 249.45, 18 million shares on the first, no named-peer day, no Fed or CPI pause, and no fill near the report. Each is defensible alone, but together they push the entry up. At 253 with a stop at 236, C risks 17 to make 33, about 1.9 to 1. At 256 it's 20 to 30, 1.5 to 1, and needs a hit rate near 40 percent. At ten percent of standard that's still a fair small bet, but this is the end of the list. Any further condition and I'd drop C rather than keep it as decoration. Check the 18 million against the 50-day average before arming, since none of us has it.

We should also admit the buy side has gotten much harder over six rounds while every sell is still one close. For new money on a fair-priced stock in a hostile tape, I accept that. But if CRM rallies through 249 without ever reclaiming 222, an underweight book gets a ten percent sleeve at 253 and nothing else. That's the price of refusing to pay mid-box, and I'd rather pay it than chase.

One last point from the sentiment report. The retail ladder of 220 support, 240 to break and 260 as the target is nearly our ladder. A level on every chart attracts wicks, and a resting limit at 222 is the order a stop run fills right before the stock keeps falling. That's one more reason to buy the close back above 222 with the stop under the whole cluster. I'd ignore the three-to-one call flow, since it's one account.

So here's why I think this is the aggressive Hold. Underweight sells a business producing about $15 billion of free cash flow, roughly 5 percent after stock comp and interest, with the weekly trend up and its stop 19 percent below. Overweight pays 236 in the middle of a range that has stopped the stock three times at 238 to 240. This version keeps the core that earns the move toward 286 and sets small, bounded, confirmed ways to own more.

Holders stay at standard weight and trim any excess into 238 to 249. On a close under 220.29 the excess goes first, then a quarter of standard, and they cut to half on a close under 214. Underweight books fill toward standard, never past it, and only after the graded gate passes, with thresholds written before the filing is opened and a three-day deadline. A is a 25 percent reclaim buy of 222, with its stop under the retest low and no higher than 214, halved or cancelled under 220.29. B is a 205 reclaim rebuild that passes the cause check. C is ten percent on two closes over 249.45, targeting 286, with A's stop trailed. One tranche is live in a decline, stopped tranches count against the 50 percent cap, and nothing fills near the print.

If Conservative is right, we skip a failed breakout and lose a bounded 1 to 2 percent of standard weight in an orderly decline, 4 to 6 percent in a gap. If I'm right, we own a fair-priced compounder about 5 percent below today's price and catch a piece of the breakout. My vote is Hold.